Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.







27.02.2022, 1695 Zeichen

Valneva: Valneva SE, an Austrian/French specialty vaccine company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has provided an initial assessment of Valneva’s inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. Valneva has received a list of questions from the CHMP and is confident that it will be able to respond to these in the coming days. Following the Company’s response, the EMA will provide a timetable towards anticipated conditional approval.
Valneva: weekly performance: 1.83%

EVN: Revenue recorded by utility company EVN Group rose by 49.1% to Euro 900.9 mn in the first quarter of 2021/22. The sharp rise in electricity prices was the main driver for this growth. The temperature-related energy demand in EVN's three core markets exceeded both the previous year and the long-term average in the first quarter of 2021/22. The market prices for natural gas, CO[2] emission certificates and base as well as peak load electricity rose to historic highs. These energy market distortions had different effects on EVN's diversified business areas: Renewable generation benefited but distribution earnings declined, while results in South East Europe were negatively affected by the increase in market prices and the related significantly higher costs for network loss coverage. EBITDA recorded by the EVN Group fell by 39.5% year-on-year to Euro 201.9 mm in the first quarter of 2021/22. Group result for the period equalled Euro 81.5 mn. This represents a year-on-year decline of 12.7%.
EVN: weekly performance: -3.39%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (25/02/2022)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #751: ATX fällt, alle Titel heute im Minus, neuer starker Partner für kapitalmarkt-stimme.at


 

Bildnachweis

1. Valneva - VLA1553: The Most Advanced Chikungunya Vaccine Candidate   >> Öffnen auf photaq.com



Aktien auf dem Radar:Polytec Group, voestalpine, Agrana, Austriacard Holdings AG, Addiko Bank, Warimpex, OMV, VIG, Semperit, RBI, Wienerberger, Cleen Energy, DO&CO, EVN, EuroTeleSites AG, Oberbank AG Stamm, Immofinanz, Mayr-Melnhof, Amag, CA Immo, Erste Group, Flughafen Wien, Österreichische Post, S Immo, Telekom Austria, Uniqa, Nike, Covestro, Siemens Energy, Rheinmetall, Airbus Group.


Random Partner

Wiener Privatbank
Die Wiener Privatbank ist eine unabhängige Privatbank mit Sitz in Wien, deren Anspruch darin liegt, die besten Investmentchancen am globalen Markt für ihre Kunden zu identifizieren. Zu den Kunden zählen Family Offices, Privatinvestoren, Institutionen sowie Stiftungen im In- und Ausland.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner